Scenarios that move VRTX
Vertex Pharmaceuticals Incorporated - Common Stock
Scenarios that move VRTX: 8 analyses, 5 positive, 3 negative.
- · RARE's Fayuvi approval triggers second $203 million PRV sale — ▼ · impact -10 · confidence low · horizon quarters
- · Mirum's Livmarli meets Phase III goal in ultra-rare liver diseases — ▼ · impact -15 · confidence low · horizon quarters
- · Viatris to acquire Pacira for $1.65B in pain portfolio deal — ▲ · impact +35 · confidence low · horizon quarters
- · Pacira BioSciences shares skyrocket in today's trading — ▲ · impact +14 · confidence low · horizon quarters
- · Liquidia stock plunges 57% after UTHR patent setback — ▼ · impact -25 · confidence low · horizon weeks
- · Mirum's Brelovitug meets goal in Phase III AZURE-1 study — ▲ · impact +15 · confidence low · horizon quarters
- · Sion cuts workforce nearly half after CF study failure — ▲ · impact +58 · confidence high · horizon immediate
- · Ascendis announces planned $400 million share repurchase program — ▲ · impact +30 · confidence low · horizon immediate